MARÍA JOSÉ
SÁNCHEZ PÉREZ
DOCENTE INVITADA
Institute of Oncology Ljubljana
Liubliana, EsloveniaPublicaciones en colaboración con investigadores/as de Institute of Oncology Ljubljana (50)
2023
-
Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage
Frontiers in Oncology, Vol. 13
-
Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3)
Neuro-Oncology, Vol. 25, Núm. 3, pp. 593-606
-
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)
Neuro-Oncology, Vol. 25, Núm. 3, pp. 580-592
2021
-
Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study
Digestive and Liver Disease, Vol. 53, Núm. 5, pp. 639-645
-
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)
Neuro-Oncology, Vol. 23, Núm. 10, pp. 1765-1776
2020
-
Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study
European Journal of Surgical Oncology, Vol. 46, Núm. 6, pp. 1151-1159
-
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
Breast Cancer Research and Treatment, Vol. 183, Núm. 2, pp. 439-450
-
Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study
Archives of Gynecology and Obstetrics, Vol. 301, Núm. 2, pp. 591-602
2019
-
Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer
International Journal of Cancer, Vol. 144, Núm. 9, pp. 2118-2127
-
Epidemiology of rare cancers and inequalities in oncologic outcomes
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 3-11
-
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 75-80
-
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 60-66
-
Treatment challenges in and outside a network setting: Head and neck cancers
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 40-45
-
Treatment challenges in and outside a network setting: Soft tissue sarcomas
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 31-39
-
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 46-51
2018
-
Trends in incidence of thick, thin and in situ melanoma in Europe
European Journal of Cancer, Vol. 92, pp. 108-118
2017
-
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
The Lancet Oncology, Vol. 18, Núm. 8, pp. 1022-1039
-
Data quality in rare cancers registraton: The report of the RARECARE data quality study
Tumori, Vol. 103, Núm. 1, pp. 22-32
-
New insights into survival trend analyses in cancer population-based studies: The SUDCAN methodology
European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S9-S15
-
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
European Journal of Cancer, Vol. 84, pp. 335-353